| Code | Description | Claims | Beneficiaries | Total Paid |
| 99215 |
Prolong outpt/office vis |
2,665 |
2,156 |
$279K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,115 |
2,570 |
$250K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,027 |
949 |
$85K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,288 |
1,216 |
$60K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
654 |
647 |
$57K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
517 |
473 |
$28K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
184 |
184 |
$16K |
| 90461 |
|
388 |
366 |
$13K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
239 |
189 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
425 |
383 |
$6K |
| 99205 |
Prolong outpt/office vis |
32 |
28 |
$4K |
| 83655 |
|
153 |
141 |
$2K |
| 81002 |
|
497 |
449 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
15 |
15 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$1K |
| 85018 |
|
559 |
546 |
$1K |
| 99381 |
|
14 |
14 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
89 |
85 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
14 |
13 |
$625.23 |
| 86580 |
|
46 |
43 |
$348.12 |
| 99050 |
|
61 |
53 |
$322.56 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
16 |
13 |
$217.60 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$188.50 |
| 36415 |
Collection of venous blood by venipuncture |
13 |
13 |
$43.56 |
| 99000 |
|
17 |
12 |
$11.78 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$8.91 |
| 90670 |
|
108 |
107 |
$0.00 |
| 99072 |
|
579 |
355 |
$0.00 |
| 90713 |
|
165 |
162 |
$0.00 |
| 90700 |
|
251 |
244 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
14 |
13 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
23 |
18 |
$0.00 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
53 |
40 |
$0.00 |
| 36416 |
|
55 |
48 |
$0.00 |
| 90686 |
|
288 |
262 |
$0.00 |
| 90680 |
|
34 |
33 |
$0.00 |
| 90744 |
|
25 |
25 |
$0.00 |